SH2D1A and slam protein expression in human lymphocytes and derived cell lines

International Journal of Cancer

Volumn 88, Issue 3, 2000, Pages 439-447

  Nagy, Noémi ^a   Cerboni, Cristina ^a   Mattsson, Karin ^a   Maeda, Akihiko ^a   Gogolák, Péter ^a   Sümegi, János ^b   Lányi, Árpád ^b   Székely, László ^a   Carbone, Ennio ^a   Klein, George ^a   Klein, Eva ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD150 ANTIGEN; GENE PRODUCT; MEMBRANE PROTEIN; PROTEIN DSHP; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE ACTIVATION; BURKITT LYMPHOMA; CONTROLLED STUDY; DOWN REGULATION; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INFECTION CONTROL; LEUKEMIA CELL LINE; LYMPHOBLASTOID CELL LINE; LYMPHOPROLIFERATIVE DISEASE; NATURAL KILLER CELL; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION; X CHROMOSOME LINKED DISORDER;

EID: 0033814931     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20001101)88:3<439::aid-ijc17>3.0.co;2-%23     Document Type: Article

References (47)

1. Direct implantation and serial transplantation of human acute lymphoblastic leukemia in hamsters, SB-2
2. Defective natural killing activity but retention of lymphocyte-mediated antibody-dependent cellular cytotoxicity in patients with the X-linked lymphoproliferative syndrome
3. Engagement of the signaling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2-independent, cyclosporin A-sensitive T cell proliferation and IFN-gamma production
4. Establishment in continuous culture of a new type of lymphocyte from a 'Burkitt like' malignant lymphoma (line D.G.-75)
5. Induction of plasmacytoid differentiation by phorbol ester in B-cell lymphoma cell lines bearing 8;14 translocations
6. Variant translocation in a non endemic case of Burkitt's lymphoma: t(8;22) in an Epstein-Barr virus negative tumour and in a derived cell line
7. Natural killer cells in antiviral defence: Function and regulation by innate cytokines
8. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48
9. Release of platelet-activating factor (PAF) like material from human lymphoid cell lines
10. Reversal of human allergic T helper 2 responses by engagement of signaling lymphocytic activation molecule
11. A novel receptor involved in T-cell activation
12. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene
13. Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji)
14. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line
15. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: Acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation
16. Immune deficiency in the X-linked lymphoproliferative syndrome. I. Epstein-Barr virus-specific defects
17. Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line
18. Computer programs that allow fast acquisition, visualization and overlap quantitation of fluorescent 3D microscopic objects by using nearest-neighbor deconvolution algorithm
19. Brief report: Killer cell defect and persistent immunological abnormalities in two patients with chronic active Epstein-Barr virus infection
20. Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines
21. Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus
22. An EBV-genome-negative cell line established from an American Burkitt lymphoma: Receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection
23. Correlation between immunoglobulin light chain expression and variant translocation in Burkitt's lymphoma
24. Characterization of lymphoma-derived cell lines: Comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics
25. X-linked lymphoproliferative disease: Pathology and diagnosis
26. Cellular immune defects to Epstein-Barr virus-determined antigens in young males
27. Establishment and characterization of an Epstein-Barr virus (EBV)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma
28. Chronic active Epstein-Barr virus infection in patients with Chediak-Higashi syndrome
29. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes
30. Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes
31. Inactivating mutations in an SH2 domain-encoding gone in X-linked lymphoproliferative syndrome
32. Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines
33. Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes
34. Epstein-Barr-virus-induced oncogenesis in immune-deficient individuals
35. X-linked lymphoproliferative disease (XLP) as a model of Epstein-Barr virus-induced immunopathology
36. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease)
37. Detection of X-linked lymphoproliferative disease using molecular and immunovirologic markers
38. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia
39. Epstein-Barr virus status and tumour cell phenotype in sporadic Burkitt's lymphoma
40. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM
41. Characterization of EBV-genome negative 'null' and 'T' cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma
42. Deficient natural killer cell activity in x-linked lymphoproliferative syndrome
43. An Epstein-Barr virus-producer line Akata: Establishment of the cell line and analysis of viral DNA
44. Human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP
45. Morphologic variations in human leukemic lymphoblasts (CCRF-CEM cells) after long-term culture and exposure to chemotherapeutic agents. A study with the electron microscope
46. TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells)